Biotech leaders at a Stanford symposium normally focused on the future couldn’t help but grapple with a present clouded by ...

Biotechnology may be the stuff that dreams are made of, but more recently, the sector has been a nightmare for investors.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...